FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Gemignani Gary G 2. Issuer Name and Ticker or Trading Symbol Bluejay Diagnostics, Inc. [ BJDX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
C/O BLUEJAY DIAGNOSTICS, INC, 360 MASSACHUSETTS AVENUE, SUITE 203
3. Date of Earliest Transaction (MM/DD/YYYY)
12/15/2021
(Street)
ACTON, MA 01720
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase common stock  $2.72  12/15/2021    A     25000       (1) 12/15/2031  Common Stock  25000   (2) 25000  D   

Explanation of Responses:
(1)  The stock options set forth in this table vest on the one-year anniversary of the date hereof, subject to the grantee's continued service to the Company on the vesting date.
(2)  The stock options were issued in connection with the reporting person's Board of Director services to the Company.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Gemignani Gary G
C/O BLUEJAY DIAGNOSTICS, INC
360 MASSACHUSETTS AVENUE, SUITE 203
ACTON, MA 01720
X



Signatures
/s/ Gary Gemignani 12/16/2021
**Signature of Reporting Person Date
Bluejay Diagnostics (NASDAQ:BJDX)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Bluejay Diagnostics Charts.
Bluejay Diagnostics (NASDAQ:BJDX)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Bluejay Diagnostics Charts.